Lemierre syndrome (LS) is a multisystemic infection beginning in the oropharynx and leading to thrombosis of the internal jugular vein (IJV) with septic emboli and potential thrombotic extension to the central nervous system. Although patient outcomes have improved with early initiation of antimicrobial therapies, there is no consensus regarding the role of anticoagulation in LS. To better define the role of anticoagulation therapy in LS and determine whether anticoagulation improves thrombosis outcomes, we conducted a retrospective chart review of pediatric and adult patients diagnosed with LS and managed at our institution from January 1998 to December 2014. Eighteen patients (9 females and 9 males) were included in this analysis, 6 of whom received ≥4 weeks of anticoagulation therapy (median 23.1 weeks, range 6.9-32.9 weeks). Six patients were in the pediatric age group (<18 years). All patients received broad-spectrum antibiotics. All patients had improvement in their thrombi by 3 months (nonanticoagulated patient group: complete response [CR], n = 9; partial response [PR], n = 3; anticoagulated patient group: CR, n = 2; PR, n = 4). No patient developed recurrent thrombosis or progression during the follow-up period, regardless of anticoagulation status. Our study suggests that anticoagulation in LS may not affect thrombosis outcomes.

Keywords:
Children and adults, Lemierre syndrome, Thrombosis, Anticoagulation
1.
Schottmuller H: Ueber die Pathogenität anaërober Bazillen. Dtsch Med Wochenschr 1918;44:1440.
2.
Lemierre A: On certain septicaemias due to anaerobic organisms. Lancet 1936;1:701-703.
3.
Jane R, Johnson P: Critical care nurses be aware: Lemierre's syndrome is on the rise. Aust Crit Care 2003;16:126-132.
4.
Ridgway JM, Parikh DA, Wright R, Holden P, Armstrong W, Camilon F, Wong BJ: Lemierre syndrome: a pediatric case series and review of literature. Am J Otolaryngol 2010;31:38-45.
5.
Karkos PD, Asrani S, Karkos CD, Leong SC, Theochari EG, Alexopoulou TD, Assimakopoulos AD: Lemierre's syndrome: a systematic review. Laryngoscope 2009;119:1552-1559.
6.
Eilbert W, Singla N: Lemierre's syndrome. Int J Emerg Med 2013;6:1-5.
7.
Riordan T: Human infection with Fusobacterium necrophorum (Necrobacillosis), with a focus on Lemierre's syndrome. Clin Microbiol Rev 2007;20:622-659.
8.
Kaplan DM, Fliss DM, Peiser Y, Greenberg D, Leiberman A: Internal jugular vein thrombosis in a child due to a ‘pencil point injury' of the palate. Int J Pediatr Otorhinolaryngol 1998;44:183-187.
9.
Palmer AL, Strain JD, Henry DB, Karrer FM, Simoes EAF: Postanginal sepsis after oropharyngeal trauma. Pediatr Infect Dis J 1995;14:249-250.
10.
Lustig LR, Cusick BC, Cheung SW, Lee KC: Lemierre's syndrome: two cases of postanginal sepsis. Otolaryngol Head Neck Surg 1995;112:767-772.
11.
Sinave CP, Hardy GJ, Fardy PW: The Lemierre syndrome: thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection. Medicine (Baltimore) 1989;68:85-94.
12.
Koay CB, Heyworth T, Burden P: Lemierre syndrome - a forgotten complication of acute tonsillitis. J Laryngol Otol 1995;109:657-661.
13.
Phua CK, Chadachan VM, Acharya R: Lemierre syndrome-should we anticoagulate? A case report and review of the literature. Int J Angiol 2013;22:137-142.
14.
Chirinos JA, Lichstein DM, Garcia J, Tamariz LJ: The evolution of Lemierre syndrome. Medicine (Baltimore) 2002;81:458-465.
15.
Armstrong AW, Spooner K, Sanders JW: Lemierre's syndrome. Curr Infect Dis Report 2000;2:168-173.
16.
Edibam C, Gharbi R, Weekes JW: Septic jugular thrombophlebitis and pulmonary embolism: a case report. Crit Care Res 2000;2:38-41.
17.
Lu MD, Vasavada Z, Tanner C: Lemierre syndrome following oropharyngeal infection: a case series. J Am Board Fam Med 2009;22:79-83.
18.
Screaton NJ, Ravenel JG, Lehner PJ, Heitzman ER, Flower CD: Lemierre syndrome: forgotten but not extinct - report of four cases. Radiology 1999;213:369-374.
19.
Ramirez S, Hild TG, Rudolph CN, Sty JR, Kehl SC, Havens P, Henrickson K, Chusid MJ: Increased diagnosis of Lemierre's syndrome and other Fusobacterium necrophorum infections at a children's hospital. Pediatrics 2003;112:e380.
20.
Lakshminarayana PH, Woodske ME: A unique case of Lemierre syndrome associated with thrombophilia in an adult and the role of anticoagulation. Case Rep Med 2010;2010: 982494.
21.
Bondy P, Grant T: Lemierre's syndrome: what are the roles for anticoagulation and long-term antibiotic therapy? Ann Otol Rhinol Laryngol 2008;117:679-683.
22.
Bouton F, Cotils M, Genard M, Hubert C: Septic thrombophlebitis of the internal jugular vein and Lemierre syndrome (in French). Rev Med Brux 1998;19:5-9.
23.
De Sena S, Rosenfeld DL, Santos S, Keller I: Jugular thrombophlebitis complicating bacterial pharyngitis (Lemierre's syndrome). Pediatr Radiol 1996;26:141-144.
24.
Dool H, Soetekouw R, van Zanten, M: Lemierre's syndrome: three cases and a review. Eur Arch Otorhinolaryngol 2005;262:651-654.
25.
Goldenberg NA, Knapp-Clevenger R, Hays T, Manco-Johnson MJ: Lemierre's and Lemierre's-like syndromes in children: survival and thromboembolic outcomes. Pediatrics 2005;116:e543-e548.
26.
Hagelskjaer Kristensen L, Prag J: Lemierre's syndrome and other disseminated Fusobacterium necrophorium infections in Denmark: a prospective epidemological and clinical survey. Eur J Clin Microbiol Infect Dis 2008;27:779-789.
27.
Hoehn KS: Lemierre's syndrome: the controversy of anticoagulation. Pediatrics 2005;115:1415-1416.
28.
Karanas YL, Yim KK, Shuster BA, Lineaweaver WC: Lemierre's syndrome: a case of postanginal septicemia and bilateral flank abscesses. Ann Plast Surg 1995;35:525-528.
29.
Ma M, Jauch EC, Johnson MC: A case of Lemierre's syndrome. Eur J Emerg Med 2003;10:139-142.
30.
Nakamura S, Sadoshima S, Doi Y, Yoshioka M, Yamashita S, Gotoh H, Onoyama K: Internal jugular vein thrombosis, Lemierre's syndrome; oropharyngeal infection with antibiotic and anticoagulation therapy - a case report. Angiology 2000;51:173-177.
31.
Venglarcik J: Lemierre's syndrome. Pediatr Infect Dis J 2003;22:921-923.
32.
Moore BA, Dekle C, Werkhaven J: Bilateral Lemierre's syndrome: a case report and literature review. Ear Nose Throat J 2002;81:234-236, 238-240, 242 passim.
33.
Chang WE, Wu LS: Lemierre's syndrome: a case report. Taiwan Soc Int Med 2007;18:287-292.
34.
Garbati MA, Ahsan AM, Hakawi AM: Lemierre's syndrome due to Klebsiella pneumoniae in a 63-year-old man with diabetes: a case report. J Med Case Rep 2012;6:97.
35.
Krishna K, Diwan AG, Gupt A: Lemierre's syndrome - the syndrome quite forgotten. J Assoc Physicians India 2012;60:60-63.
36.
Lim AL, Pua KC: Lemierre syndrome. Med J Malaysia 2012;67:340-341.
37.
Tsai YJ, Lin YC, Harnnd DJ, Chiang RP, Wu HM: A Lemierre syndrome variant caused by Klebsiella pneumoniae. J Formos Med Assoc 2012;111:403-405.
38.
Syed MI, Baring D, Addidle M, Murray C, Adams C: Lemierre syndrome: two cases and a review. Laryngoscope 2007;117:1605-1610.
39.
Repanos C, Chadha NK, Griffiths MV: Sigmoid sinus thrombosis secondary to Lemierre's syndrome. Ear Nose Throat J 2006;85:98-101.
40.
Dudani R, Jacobs N: An unusual sore throat. Pediatr Ann 2008;37:783-785.
41.
Schmid T, Miskin H, Schlesinger Y, Argaman Z, Kleid D: Respiratory failure and hypercoagulability in a toddler with Lemierre's syndrome. Pediatrics 2005;115:e620-e622.
42.
Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ: Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N Engl J Med 2004;351:1081-1088.
43.
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, Stevens SM, Vintch JRE, Wells P, Woller SC, Moores L: Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest 2016;149:315-352.
44.
Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ: Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:7S-47S.
45.
Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, Frulla M, Mosena L, Tormene D, Piccioli A, Simioni P, Girolami A: Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002;137:955-960.
46.
Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE Jr: Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg 1993;18:596-605, discussion 606-608.
47.
Cohen MB, Pernoll ML, Gevirtz CM, Kerstein MD: Septic pelvic thrombophlebitis: an update. Obstet Gynecol 1983;62:83-89.
48.
Josey WE, Staggers SR Jr: Heparin therapy in septic pelvic thrombophlebitis: a study of 46 cases. Am J Obstet Gynecol 1974;120:228-233.
49.
Rao AA, Kumar R, Arteaga GM, Galardy PJ, Rodriguez V: Non-catheter related internal jugular vein thrombosis in a patient with severe haemophilia A. Haemophilia 2009;15:1339-1340.
50.
Girolami A, Scandellari R, Zanon E, Sartori R, Girolami B: Non-catheter associated venous thrombosis in hemophilia A and B: a critical review of all reported cases. J Thromb Thrombolysis 2006;21:279-284.
51.
Jones TH, Bergvall V, Bradshaw JP: Carotid artery stenoses and thrombosis secondary to cavernous sinus thromboses in Fusobacterium necrophorum meningitis. Postgrad Med J 1990;66:747-750.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.